SCHEMBL1165050

SCHEMBL1165050

CCOB(CC)CC

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3899901 0.72
SCHEMBL2378319 0.69
SCHEMBL27913833 0.67 ALDH1A1 (0.32)
SCHEMBL3890570 0.67 ALDH1A1 (0.32)
SCHEMBL5049308 0.67
SCHEMBL50777 0.67 ALDH1A1 (0.32)
SCHEMBL10782213 0.65
SCHEMBL4305172 0.65
Fluoride SCHEMBL23120036 0.64 ALDH1A1 (0.30)
SCHEMBL96260 0.64

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 167 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-105985458-B Silica gel/clay composite carrier, chromium catalyst, preparation method and application thereof 中国石油天然气股份有限公司 2018-12-25 CN claimed
CN-105985458-A Silica gel/clay composite carrier, chromium catalyst, preparation method and application thereof 中国石油天然气股份有限公司 2016-10-05 CN claimed
US-8846915-B2 Process for the manufacture of rosuvastatin calcium using crystalline rosuvastatin ethyl ester AUROBINDO PHARMA LTD. (IN) 2014-09-30 US claimed
US-8759518-B2 Intermediates for the preparation of HMG CoA reductase inhibitors and processes for the preparation thereof CADILA HEALTHCARE LIMITED (IN) 2014-06-24 US claimed
US-20130158263-A1 INTERMEDIATES FOR THE PREPARATION OF HMG COA REDUCTASE INHIBITORS AND PROCESSES FOR THE PREPARATION THEREOF CADILA HEALTHCARE LIMITED (IN) 2013-06-20 US claimed
US-8212035-B2 Process for preparation of rosuvastatin calcium field of the invention AUROBINDO PHARMA LTD. (IN) 2012-07-03 US claimed
EP-2467363-A1 PROCESS FOR THE MANUFACTURE OF ROSUVASTATIN CALCIUM USING CRYSTALLINE ROSUVASTATIN ETHYL ESTER Aurobindo Pharma Limited (IN) 2012-06-27 EP claimed
US-20120149905-A1 PROCESS FOR THE MANUFACTURE OF ROSUVASTATIN CALCIUM USING CRYSTALLINE ROSUVASTATIN ETHYL ESTER AUROBINDO PHARMA LTD (IN) 2012-06-14 US claimed
WO-2011104725-A2 HMG-COA REDUCTASE INHIBITORS AND PROCESS FOR THE PREPARATION THEREOF CADILA HEALTHCARE LIMITED (IN) 2011-09-01 WO claimed
WO-2011021058-A1 PROCESS FOR THE MANUFACTURE OF ROSUVASTATIN CALCIUM USING CRYSTALLINE ROSUVASTATIN ETHYL ESTER AUROBINDO PHARMA LIMITED (IN) 2011-02-24 WO claimed
US-20090312547-A1 PROCESS FOR PREPARATION OF ROSUVASTATIN CALCIUM FIELD OF THE INVENTION AUROBINDO PHARMA LTD (IN) 2009-12-17 US claimed
EP-2125754-A1 AN IMPROVED PROCESS FOR PREPARATION OF ROSUVASTATIN CALCIUM Aurobindo Pharma Limited (IN) 2009-12-02 EP claimed
WO-2009118598-A1 PROCESS FOR THE MANUFACTURE OF ROSUVASTATIN CALCIUM WITH HIGH PURITY AUROBINDO PHARMA LIMITED (IN) 2009-10-01 WO claimed
WO-2008096257-A1 AN IMPROVED PROCESS FOR PREPARATION OF ROSUVASTATIN CALCIUM AUROBINDO PHARMA LIMITED (IN) 2008-08-14 WO claimed
US-7091290-B2 Method for preparing homo-and co-polymers of cyclic olefin compounds using an organic boron compound as a catalyst activator KOREA KUMHO PETROCHEMICAL CO., LTD. (KR) 2006-08-15 US claimed
US-20050245703-A1 addition polymerization of nonaromatic cyclic olefins, such as alkylnorbornenes and dicyclopentadienes, in the presence of a catalyst complex also including a nickel II carboxylate and an aluminoxane compound; high molecular weight polymer in high yields; gelation inhibition KOREA KUMHO PETROCHEMICAL CO., LTD. (KR) 2005-11-03 US claimed
US-5218138-A Forming a complex with dialkylated borane and reducing the complex RHONE-POULENC RORER PHARMACEUTICALS INC. (US) 1993-06-08 US claimed
US-12582745-B2 Adhesive composition for hard tissue repair JIAXING JINGYIN BIOTECHNOLOGY CO., LTD (CN) 2026-03-24 US disclosed
US-4824959-A Intermediates for antihypercholesterolemic tetrazole compounds BRISTOL-MYERS COMPANY (US) 1989-04-25 US disclosed
WO-1988006584-A1 ANTIHYPERCHOLESTEROLEMIC TETRAZOLE COMPOUNDS BRISTOL-MYERS COMPANY (US) 1988-09-07 WO disclosed